The gut fungal and bacterial microbiota in pediatric patients with inflammatory bowel disease introduced to treatment with anti-tumor necrosis factor-α

Pediatric inflammatory bowel disease (PIBD) is a globally increasing chronic inflammatory disease associated with an imbalanced intestinal microbiota and treated with several treatment options, including anti-tumor necrosis factor alpha (TNF-α), such as infliximab (IFX). Up to half of the patients d...

Descripción completa

Detalles Bibliográficos
Autores principales: Ventin-Holmberg, Rebecka, Höyhtyä, Miikka, Saqib, Schahzad, Korpela, Katri, Nikkonen, Anne, Salonen, Anne, de Vos, Willem M., Kolho, Kaija-Leena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9033777/
https://www.ncbi.nlm.nih.gov/pubmed/35459927
http://dx.doi.org/10.1038/s41598-022-10548-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9033777/
https://www.ncbi.nlm.nih.gov/pubmed/35459927
http://dx.doi.org/10.1038/s41598-022-10548-7

Ejemplares similares